Costimulation loss enhances IL-2-driven Treg generation by PI3K-STAT3 inhibition in CNS autoimmunity

  • Nam, Kyung-Ho; 
  • Kim, Gil-Ran; 
  • Kim, Yu-Rim; 
  • Kwon, Young Nam; 
  • Kim, Sung-Min; 
  • 외 1명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Costimulation blockade with CTLA-4 Ig (Abatacept) is a widely used strategy to suppress autoreactive T cells; however, its efficacy is often self-limiting due to concurrent depletion of regulatory T cells (Tregs), which depend on CD28 signaling for homeostasis. Here, we demonstrate that costimulation blockade paradoxically potentiates IL-2-driven Treg generation by selectively reprogramming intracellular cytokine signaling. We identified that IL-2 activates STAT3 only in the presence of TCR stimulation, as this pathway requires CD28-mediated PI3K-AKT signaling, which is abrogated by costimulation blockade. Consequently, CTLA-4 Ig uncouples STAT3 activation from IL-2 signaling while sparing STAT5, thereby enhancing TGF-beta/Smad2/3 signaling to induce Foxp3 expression. This dual action-sustained STAT5 activation and increased Smad2/3 signaling-promoted robust Treg generation that ameliorated experimental autoimmune encephalomyelitis (EAE). Furthermore, we confirmed that this synergistic effect is conserved in human T cells from patients with multiple sclerosis (MS) upon CTLA-4 Ig and IL-2 cotreatment. Our findings suggest a strategy to expand the utility of CTLA-4 Ig therapy, providing a mechanistic rationale for combining costimulation blockade with IL-2 to restore immune tolerance in CNS autoimmunity.

키워드

REGULATORY T-CELLS; CYTOPLASMIC DOMAIN; CTLA-4; INTERLEUKIN-2; ABATACEPT; ACTIVATION; CD28; DISEASE; ANTIGEN; PROTEIN
제목
Costimulation loss enhances IL-2-driven Treg generation by PI3K-STAT3 inhibition in CNS autoimmunity
저자
Nam, Kyung-Ho; Kim, Gil-Ran; Kim, Yu-Rim; Kwon, Young Nam; Kim, Sung-Min; Choi, Je-Min
DOI
10.1038/s44321-026-00431-7
발행일
2026-05
유형
Article; Early Access
저널명
EMBO Molecular Medicine